Ueno H, Sano M, Hara M, Noji H
ACS Sens. 2023; 8(9):3400-3407.
PMID: 37590841
PMC: 10521141.
DOI: 10.1021/acssensors.3c00587.
Chang C, Few L, Lim B, Yvonne-Tee G, Chew A, See Too W
Parasitol Res. 2023; 122(7):1651-1661.
PMID: 37202563
DOI: 10.1007/s00436-023-07869-5.
Ma Q, Jiang H, Ma L, Zhao G, Xu Q, Guo D
Proc Natl Acad Sci U S A. 2023; 120(15):e2209435120.
PMID: 37011206
PMC: 10104498.
DOI: 10.1073/pnas.2209435120.
Rabeler C, Chen M, Kaplinsky N
Front Plant Sci. 2022; 13:851960.
PMID: 35574129
PMC: 9100391.
DOI: 10.3389/fpls.2022.851960.
Jaswal A, Hazari P, Prakash S, Sethi P, Kaushik A, Roy B
ACS Omega. 2022; 7(15):12509-12523.
PMID: 35474820
PMC: 9025991.
DOI: 10.1021/acsomega.1c04256.
Choline Kinase Alpha2 Promotes Lipid Droplet Lipolysis in Non-Small-Cell Lung Carcinoma.
Zhu R, Yang Y, Shao F, Wang J, Gao Y, He J
Front Oncol. 2022; 12:848483.
PMID: 35463311
PMC: 9021865.
DOI: 10.3389/fonc.2022.848483.
Bi-allelic variants in CHKA cause a neurodevelopmental disorder with epilepsy and microcephaly.
Klockner C, Fernandez-Murray J, Tavasoli M, Sticht H, Stoltenburg-Didinger G, Scholle L
Brain. 2022; 145(6):1916-1923.
PMID: 35202461
PMC: 9630884.
DOI: 10.1093/brain/awac074.
Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019.
Wang N, Brickute D, Braga M, Barnes C, Lu H, Allott L
Pharmaceutics. 2021; 13(7).
PMID: 34371769
PMC: 8309005.
DOI: 10.3390/pharmaceutics13071078.
Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases.
Lacal J, Zimmerman T, Campos J
Pharmaceutics. 2021; 13(6).
PMID: 34070409
PMC: 8226952.
DOI: 10.3390/pharmaceutics13060788.
ChoK-ing the Pathogenic Bacteria: Potential of Human Choline Kinase Inhibitors as Antimicrobial Agents.
Khalifa M, Few L, See Too W
Biomed Res Int. 2020; 2020:1823485.
PMID: 32695809
PMC: 7368946.
DOI: 10.1155/2020/1823485.
A kinase bioscavenger provides antibiotic resistance by extremely tight substrate binding.
Terekhov S, Mokrushina Y, Nazarov A, Zlobin A, Zalevsky A, Bourenkov G
Sci Adv. 2020; 6(26):eaaz9861.
PMID: 32637600
PMC: 7314540.
DOI: 10.1126/sciadv.aaz9861.
Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase.
Kall S, Whitlatch K, Smithgall T, Lavie A
Sci Rep. 2019; 9(1):17121.
PMID: 31745227
PMC: 6864063.
DOI: 10.1038/s41598-019-53447-0.
Plasmodium falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death.
Serran-Aguilera L, Denton H, Rubio-Ruiz B, Lopez-Gutierrez B, Entrena A, Izquierdo L
Sci Rep. 2016; 6:33189.
PMID: 27616047
PMC: 5018819.
DOI: 10.1038/srep33189.
Genomic Analysis of Genes Involved in the Biosynthesis of Very Long Chain Polyunsaturated Fatty Acids in Thraustochytrium sp. 26185.
Zhao X, Dauenpen M, Qu C, Qiu X
Lipids. 2016; 51(9):1065-75.
PMID: 27514858
DOI: 10.1007/s11745-016-4181-6.
Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation.
Wong M, Chen S
J Virol. 2016; 90(20):9075-95.
PMID: 27489281
PMC: 5044849.
DOI: 10.1128/JVI.00960-16.
The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.
Trousil S, Kaliszczak M, Schug Z, Nguyen Q, Tomasi G, Favicchio R
Oncotarget. 2016; 7(24):37103-37120.
PMID: 27206796
PMC: 5095062.
DOI: 10.18632/oncotarget.9466.
Phosphorylation of Human Choline Kinase Beta by Protein Kinase A: Its Impact on Activity and Inhibition.
Chang C, Few L, Konrad M, See Too W
PLoS One. 2016; 11(5):e0154702.
PMID: 27149373
PMC: 4858151.
DOI: 10.1371/journal.pone.0154702.
Importance of Skin Changes in the Differential Diagnosis of Congenital Muscular Dystrophies.
Yis U, Baydan F, Karakaya M, Kurul S, Cirak S
Biomed Res Int. 2016; 2016:3128735.
PMID: 27123443
PMC: 4830701.
DOI: 10.1155/2016/3128735.
Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.
Arlauckas S, Popov A, James Delikatny E
Prog Lipid Res. 2016; 63:28-40.
PMID: 27073147
PMC: 5360181.
DOI: 10.1016/j.plipres.2016.03.005.
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1).
Schiaffino-Ortega S, Baglioni E, Mariotto E, Bortolozzi R, Serran-Aguilera L, Rios-Marco P
Sci Rep. 2016; 6:23793.
PMID: 27029499
PMC: 4814829.
DOI: 10.1038/srep23793.